Rajeev A, Katukuri S, Devarashetty S, Dantala S, Billa AL. Expression of p120 – catenin in oral squamous cell carcinoma and apparently normal mucosa adjacent to oral squamous cell carcinoma. J Clin Exp Dent. 2024;16(4):e391-8.

doi:10.4317/jced.61057

______

References

1. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67-76. https://doi.org/10.1016/j.tripleo.2005.07.038 PMid:16831675

2. Coelho K. Challenges of the Oral Cancer Burden in India. J Cancer Epi. 2012;2012:1-17. https://doi.org/10.1155/2012/701932 PMid:23093961 PMCid:PMC3471448

3. Li L, Ji S, Shrestha C, Jiang Y, Liao L, Xu F, et al. p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling. J Cell Physiol. 2020;235:9399-9413. https://doi.org/10.1002/jcp.29744 PMid:32356317 PMCid:PMC7529923

4. Lopez-Verdín S, Soto-Avila JJ, Zamora-Perez AL, Lazalde-Ramos BP, Martínez-Fierro ML, Gonzalez-González R et al. Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva. Med Oral Patol Oral Cir Bucal. 2017;22:e694-e701. https://doi.org/10.4317/medoral.21907 PMid:29053653 PMCid:PMC5813987

5. Montero H, Patel S. Cancer of the Oral Cavity. Surg Oncol Clin N Am. 2015;24:491-508. https://doi.org/10.1016/j.soc.2015.03.006 PMid:25979396 PMCid:PMC5018209

6. Warnakulasuriya S. Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol. 2010;46:407-410. https://doi.org/10.1016/j.oraloncology.2010.02.015 PMid:20403722

7. Scully CB, Bagan J. Review - Oral squamous cell carcinoma overview. Oral Oncol. 2009;45:301-308. https://doi.org/10.1016/j.oraloncology.2009.01.004 PMid:19249237

8. Ma LW, Zhou ZT, He QB, Jiang WW. Phosphorylated p120-catenin expression has predictive value for oral cancer progression. J Clin Pathol. 2012;65:315-9. https://doi.org/10.1136/jclinpath-2011-200516 PMid:22259181

9. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck. 2009;31:1600-9. https://doi.org/10.1002/hed.21131 PMid:19455705

10. Nankivell P, Mehanna H. Oral dysplasia: biomarkers, treatment, and follow-up. Curr Oncol Rep. 2011;13:145e52. https://doi.org/10.1007/s11912-010-0150-z PMid:21249481

11. Nomura T, Shibahara T. Detection of field alterations using useful tools for oral squamous cell carcinoma. Jpn Dent Sci Rev. 2013;49:106-115. https://doi.org/10.1016/j.jdsr.2013.04.001

12. Introduction-Taking stock: The many surprising lives of p120-catenins. Biochim Biophys Acta. 2007;1773:1. https://doi.org/10.1016/j.bbamcr.2006.10.004

13. Stairs DB. Deletion of p120-Catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell. 2011;19:470-483. https://doi.org/10.1016/j.ccr.2011.02.007 PMid:21481789 PMCid:PMC3077713

14. Ishizaki Y, Omori Y, Momiyama M, Nishikawa Y, Tokairin T, Manabe M et al. Reduced expression and aberrant localization of p120catenin in human squamous cell carcinoma of the skin. J Dermatol Sci. 2004;34:99-108. https://doi.org/10.1016/j.jdermsci.2003.12.001 PMid:15033192

15. Silva Neto B, Smith GL, Mandeville JA, Vanni AJ, Wotkowicz C, Rieger-Christ KM et al. Prognostic significance of altered p120 ctn expression in bladder cancer. BJU Int. 2008;101:746-52. https://doi.org/10.1111/j.1464-410X.2007.07264.x PMid:17922855

16. Wijnhoven BP, Pignatelli M, Dinjens WN, Tilanus HW. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. J Surg Oncol. 2005;92:116-23. https://doi.org/10.1002/jso.20344 PMid:16231374

17. Schackmann RC, Klarenbeek S, Vlug EJ, Stelloo S, van Amersfoort M, Tenhagen M, et al. Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res. 2013;73:4937-4949. https://doi.org/10.1158/0008-5472.CAN-13-0180 PMid:23733751

18. van Hengel J, Van den Broeke C, Pieters T, Libbrecht L, Hofmann I, van Roy F. Inactivation of p120 catenin in mice disturbs intrahepatic bile duct development and aggravates liver carcinogenesis. Eur J Cell Biol. 2016;95:574-584. https://doi.org/10.1016/j.ejcb.2016.10.003 PMid:27769530

19. Venhuizen JH, Span PN, van den Dries K, Sommer S, Friedl P, Zegers MM. P120 Catenin Isoforms Differentially Associate with Breast Cancer Invasion and Metastasis. Cancers. 2019;11:1459. https://doi.org/10.3390/cancers11101459 PMid:31569498 PMCid:PMC6826419

20. Lo Muzio L, Pannone G, Santarelli A, Bambini F, Mascitti M, Rubini C et al. Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor? Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:789-98. https://doi.org/10.1016/j.oooo.2013.03.006 PMid:23706919

21. Pegilion F, Etienne-Manneville S. p120catenin alteration in cancer and its role in tumour invasion. Phil Trans R Soc B. 2013;368:20130015. https://doi.org/10.1098/rstb.2013.0015 PMid:24062585 PMCid:PMC3785965

22. Schackmann RC, Tenhagen M, van de Ven RA, Derksen PW. p120-catenin in cancer - mechanisms, models and opportunities for intervention. J Cell Sci. 2013;126:3515-25. https://doi.org/10.1242/jcs.134411 PMid:23950111

23. Venhuizen JH, Jacobs FJC, Span PN, Zegers MM. P120 and E-cadherin: Double-edged swords in tumor metastasis. Semin Cancer Biol. 2020;60:107-120. https://doi.org/10.1016/j.semcancer.2019.07.020 PMid:31369816

24. Wu Q, Li G, Wen C, Zeng T, Fan Y, Liu C, et al. Monoubiquitination of p120-catenin is essential for TGFβ-induced epithelial-mesenchymal transition and tumor metastasis. Sci Adv. 2020;6:eaay9819. https://doi.org/10.1126/sciadv.aay9819 PMid:32010791 PMCid:PMC6976293

25. Jain S. Biomarkers and Chemopreventives: Role In Oral Carcinogenesis. Dental Impact. 2012;4.

26. Jiang Y, Liao L, Shrestha C, Ji S, Chen Y, Peng J, et al. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8:9042-51. PMid:26464646 PMCid:PMC4583878

27. Sasaya K, Sudo H, Maeda G, Kawashiri S, Imai K. Concomitant Loss of p120-Catenin and β-Catenin Membrane Expression and Oral Carcinoma Progression with E-Cadherin Reduction. PLoS ONE. 2013;8:e69777. https://doi.org/10.1371/journal.pone.0069777 PMid:23936352 PMCid:PMC3735538

28. Phattarataratip E, Kositkittiwanit N, Kajornkiatkul P, Yeunyong P, Ratanapitak R. P120 catenin expression and its correlation with E-cadherin in salivary gland neoplasms. J Oral Biol Craniofac Res. 2019;9:57-62. https://doi.org/10.1016/j.jobcr.2018.09.005 PMid:30258767 PMCid:PMC6153422

29. Chen T, Wang C, Wu F, Zhang X, Yang H, Deng X, et al. Altered Localization of p120 Catenin in the Cytoplasm Rather than the Membrane Correlates with Poor Prognosis in Esophageal Squamous Cell Carcinoma. PLoS ONE. 2015;10:e0118645. https://doi.org/10.1371/journal.pone.0118645 PMid:25785604 PMCid:PMC4364898

30. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Serpico R, Fanali S, et al. p120(cat) Delocalization in cell lines of oral cancer. Oral Oncol. 2002;38:64-72. https://doi.org/10.1016/S1368-8375(01)00027-6 PMid:11755823